CGGMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CGGMED
Largest movements
- Cash +€176,388
up €176,388 (+171.3%), from €102,981 to €279,369
mainly Current investments (+€125,000) and Other debts (+€109,266)
- Current investments -€125,000
no longer reported in 2025 (was €125,000)
- Receivables within one year -€28,670
down €28,670 (-19.7%), from €145,500 to €116,830
of which Other amounts receivable: -€31,000
- Tangible fixed assets +€19,297
up €19,297 (+1439.3%), from €1,341 to €20,638
- Other debts +€109,266
up €109,266 (+304.3%), from €35,907 to €145,173
- Reserves -€63,500
down €63,500 (-22.0%), from €288,360 to €224,860
- Gross operating margin +€8,547
up €8,547 (+8.0%), from €106,272 to €114,819
- Depreciation +€5,011
up €5,011 (+394.9%), from €1,269 to €6,280
- Financial income +€4,386
up €4,386 (+110.9%), from €3,955 to €8,341
- Other operating charges +€1,627
up €1,627 (+240.2%), from €677 to €2,305
- Taxes +€1,289
up €1,289 (+4.2%), from €30,595 to €31,883
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €381,654 | €426,550 | +€44,896 | +11.8% |
| Fixed assets | 21/28 | €1,366 | €20,663 | +€19,297 | +1412.9% |
| Tangible fixed assets | 22/27 | €1,341 | €20,638 | +€19,297 | +1439.3% |
| Furniture and vehicles | 24 | €1,341 | €20,638 | +€19,297 | +1439.3% |
| Financial fixed assets | 28 | €25 | €25 | = | 0.0% |
| Current assets | 29/58 | €380,288 | €405,887 | +€25,599 | +6.7% |
| Amounts receivable within one year | 40/41 | €145,500 | €116,830 | -€28,670 | -19.7% |
| Trade receivables | 40 | - | €2,330 | +€2,330 | |
| Other amounts receivable | 41 | €145,500 | €114,500 | -€31,000 | -21.3% |
| Current investments | 50/53 | €125,000 | - | -€125,000 | |
| Cash at bank and in hand | 54/58 | €102,981 | €279,369 | +€176,388 | +171.3% |
| Deferred charges and accrued income | 490/1 | €6,807 | €9,688 | +€2,880 | +42.3% |
| Total equity and liabilities | 10/49 | €381,654 | €426,550 | +€44,896 | +11.8% |
| Equity | 10/15 | €306,191 | €243,407 | -€62,784 | -20.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €288,360 | €224,860 | -€63,500 | -22.0% |
| Distributable reserves | 133 | €288,360 | €224,860 | -€63,500 | -22.0% |
| Profit (loss) carried forward | 14 | €5,431 | €6,147 | +€716 | +13.2% |
| Amounts payable | 17/49 | €75,463 | €183,143 | +€107,679 | +142.7% |
| Amounts payable within one year | 42/48 | €73,713 | €180,893 | +€107,179 | +145.4% |
| Current portion of amounts payable after more than one year | 42 | €3,836 | €3,826 | -€10 | -0.3% |
| Trade debts | 44 | €759 | €10 | -€749 | -98.7% |
| Suppliers | 440/4 | €759 | €10 | -€749 | -98.7% |
| Taxes, remuneration and social security | 45 | €33,211 | €31,883 | -€1,328 | -4.0% |
| Taxes | 450/3 | €30,681 | €31,883 | +€1,202 | +3.9% |
| Remuneration and social security | 454/9 | €2,530 | - | -€2,530 | |
| Other amounts payable | 47/48 | €35,907 | €145,173 | +€109,266 | +304.3% |
| Accrued charges and deferred income | 492/3 | €1,750 | €2,250 | +€500 | +28.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,269 | €6,280 | +€5,011 | +394.9% |
| Other operating charges | 640/8 | €677 | €2,305 | +€1,627 | +240.2% |
| Gross operating margin | 9900 | €106,272 | €114,819 | +€8,547 | +8.0% |
| Operating profit (loss) | 9901 | €104,326 | €106,234 | +€1,909 | +1.8% |
| Financial income | 75/76B | €3,955 | €8,341 | +€4,386 | +110.9% |
| Recurring financial income | 75 | €3,955 | €8,341 | +€4,386 | +110.9% |
| Financial charges | 65/66B | €998 | €976 | -€22 | -2.3% |
| Recurring financial charges | 65 | €998 | €976 | -€22 | -2.3% |
| Profit (loss) for the period before taxes | 9903 | €107,283 | €113,600 | +€6,317 | +5.9% |
| Income taxes | 67/77 | €30,595 | €31,883 | +€1,289 | +4.2% |
| Profit (loss) for the period | 9904 | €76,688 | €81,716 | +€5,028 | +6.6% |
| Profit (loss) for the period to be appropriated | 9905 | €76,688 | €81,716 | +€5,028 | +6.6% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.